1-7 of 7
Yoshihiro Matsuno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of p16 Homozygous Deletions with Clinicopathologic Characteristics and EGFR/KRAS/p53 Mutations in Lung Adenocarcinoma

Reika Iwakawa, Takashi Kohno, Yoichi Anami, Masayuki Noguchi, Kenji Suzuki, Yoshihiro Matsuno, Kazuhiko Mishima, Ryo Nishikawa, Fumio Tashiro, Jun Yokota
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3746–3753.
https://doi.org/10.1158/1078-0432.CCR-07-4552
Published: 16 June 2008
View articletitled, Association of p16 Homozygous Deletions with Clinicopathologic Characteristics and EGFR/KRAS/p53 Mutations in Lung Adenocarcinoma
Open the PDF for Association of p16 Homozygous Deletions with Clinicopathologic Characteristics and EGFR/KRAS/p53 Mutations in Lung Adenocarcinoma in another window
Journal Articles

Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib

Toshimi Takano, Yuichiro Ohe, Koji Tsuta, Tomoya Fukui, Hiromi Sakamoto, Teruhiko Yoshida, Ukihide Tateishi, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine, Hideo Kunitoh, Yoshihiro Matsuno, Koh Furuta, Tomohide Tamura
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5385–5390.
https://doi.org/10.1158/1078-0432.CCR-07-0627
Published: 17 September 2007
View articletitled, Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib
Open the PDF for Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib in another window
Journal Articles

Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

Tetsuya Okano, Tadashi Kondo, Kiyonaga Fujii, Toshihide Nishimura, Toshimi Takano, Yuichiro Ohe, Koji Tsuta, Yoshihiro Matsuno, Akihiko Gemma, Harbumi Kato, Shoji Kudoh, Setsuo Hirohashi
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (3): 799–805.
https://doi.org/10.1158/1078-0432.CCR-06-1654
Published: 08 February 2007
View articletitled, Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Open the PDF for Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features

Tatsuhiro Shibata, Satomi Uryu, Akiko Kokubu, Fumie Hosoda, Misao Ohki, Tokuki Sakiyama, Yoshihiro Matsuno, Ryosuke Tsuchiya, Yae Kanai, Tadashi Kondo, Issei Imoto, Johji Inazawa, Setsuo Hirohashi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6177–6185.
https://doi.org/10.1158/1078-0432.CCR-05-0293
Published: 06 September 2005
View articletitled, Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features
Open the PDF for Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features in another window
Journal Articles

Promoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non–Small Cell Lung Cancer

Shinji Kikuchi, Daisuke Yamada, Takeshi Fukami, Mari Masuda, Mika Sakurai-Yageta, Yuko N. Williams, Tomoko Maruyama, Hisao Asamura, Yoshihiro Matsuno, Masataka Onizuka, Yoshinori Murakami
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (8): 2954–2961.
https://doi.org/10.1158/1078-0432.CCR-04-2206
Published: 18 April 2005
View articletitled, Promoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non–Small Cell Lung Cancer
Open the PDF for Promoter Methylation of DAL-1/4.1B Predicts Poor Prognosis in Non–Small Cell Lung Cancer in another window
Journal Articles

Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma

Toshiro Niki, Sanae Iba, Masahide Tokunou, Tesshi Yamada, Yoshihiro Matsuno, Setsuo Hirohashi
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2431–2439.
Published: 01 June 2000
View articletitled, Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma
Open the PDF for Expression of Vascular Endothelial Growth Factors A, B, C, and D and Their Relationships to Lymph Node Status in Lung Adenocarcinoma in another window
Journal Articles

Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma

Yoshio Tomizawa, Jun-ichi Adachi, Takashi Kohno, Kunihiro Hamada, Ryusei Saito, Masayuki Noguchi, Yoshihiro Matsuno, Setsuo Hirohashi, Naohito Yamaguchi, Jun Yokota
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (5): 1139–1146.
Published: 01 May 1999
View articletitled, Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma
Open the PDF for Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma in another window